arrow
R

Rolf Turk

integrated dna technologies
H指数:23
被引数:2,575

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems

作者更正:UNCOVERseq实现了对CRISPR-Cas模态和系统中敏感且可控的基因编辑脱靶位点的鉴定

2026-10-120
OAAI
UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems

UNCOVERseq 实现了跨CRISPR-Cas模态和系统的敏感且可控的基因编辑脱靶位点鉴定

2026-08-110
OA
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation

他克莫司抵抗性调节性T细胞的临床开发以实现同时免疫抑制和免疫调节

2026-05-012
OAAI
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines (vol 12, 3908, 2021)
2021-07-193
OAAI
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

AsCas12a超核酸酶促进治疗细胞药物的快速生成

2021-06-2377
OAAI
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
2020-07-2724
OAAI
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
2018-08-06595
OAAI